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Sdischarge. Retroperitoneal bleeding, pseudoaneurysm, arteriovenosus ﬁstula and
hematoma were considered the composite endpoint of major vascular complications
(MVC). Secondary endpoints were: death, stroke, myocardial infarction, amputation
and target lesion revascularization (TLR).
Results: The study cohort had average age of 79 (range 70- 95) years compared to
60.9 in the control group (range 38- 69). Study group were more likely to be female,
but less likely to be current smokers, diabetic and dialysis reliant (p < 0.001). There
were no differences between groups in VCD deployment and critical limb ischemia.
The mean time to ambulation in the elderly and control group were 3.6 hours (1.2)
and 3.4 hours (1.3) respectively (p¼ 0.8). In 24 hours as well as in 30 days follow up
there were no signiﬁcant differences in the primary and secondary endpoints between
groups. Current smoking status (OR¼2.35, 95% CI: 0.485- 11.46) in the octogenar-
ians, whereas female sex (OR¼ 1.75, 95% CI: 0.389- 7.86) and hypercholesterolemia
(OR¼ 6.739, 95% CI: 0.294- 154.4) in controls were found to be independent
predictors of MVC at 30 days.
Conclusions: The same day discharge after ER on lower extremities is safe and
feasible in the elderly.
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Background: The atherosclerosis plaques have different morphology from soft
neointimal plaques to hard calciﬁed lesions. Therefore, we sought to evaluate the
efﬁcacy of percutaneous balloon angioplasty (PTA) versus atherectomy (AT) endo-
vascular revascularization which type was attuned by operator.
Methods: Between 2008 and 2013 a total of 419 endovascular revascularizations were
performed on arteries of lower extremities. In this registry we include patients with
claudication as well as with critical limb ischemia (CLI). The endpoints were
considered as target lesion revascularization (TLR), amputation, major adverse
cardiovascular event (MACE) and bailout stenting (BS). MACE was deﬁned as death,
myocardial infarction and stroke. The type of atherectomy (excisional- soft plaque,
orbital- calciﬁed plaque, with active aspiration- with a thrombus) was left to the
operator's discretion
Results: The PTA was performed on 215 patients, whereas AT was used in 204 cases
(Silver Hawk TM, EV3- MN, USA -125; CSI360 MN, USA- 66 Pathway Medical
Technologies- 13). The mean follow up time was 500 (454) days. There were no
signiﬁcant differences in baseline characteristics between groups with the exception of
increased coronary artery disease, dialysis and CLI for PTA group. There were
signiﬁcant differences in TVR (PTA: 32% vs. AT: 21%; p¼0.01), death (PTA8% vs.
AT: 2%; p¼0.009) and BS (PTA:9% vs. AT:1% p<0.001). Kaplan- Mayer analysis
showed no signiﬁcant differences between groups in time to TLR, amputation, death.
After adjustment this was sustained.
Conclusions: In this observational analysis, atherectomy endovascular revasculari-
zation offered better long term outcomes than balloon angioplasty.
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Background: Primary Patency (PP) in trials assessing Superﬁcial Femoral Artery
(SFA) stenting is deﬁned as a combination of vessel patency assessed by Duplex
ultrasound (DUS) at 12 month visit and freedom from revascularization of the index
vessel through 12 month follow-up. Patients are thus more likely to lose PP during the
mandated DUS assessment. Moreover, DUS is performed within a pre-speciﬁed
window which exceeds 12 months, thus the time frame for analyzing patency via DUS
exceeds the time frame by which revascularization is captured. There are no guidelines
as to the correct method for presenting these analysis in reports from clinical trials. We
aimed to analyze the implications of applying different methods in assessing freedom
from loss of PP in studies assessing stenting for SFA disease.
Methods: We simulated a dataset of patients and outcomes based on existing
available results from SFA stenting trials. Six different approaches to Kaplan Meier
(KM) analyses were applied based on entry criteria into and time frame of the KM
model.
Results: Six KM estimates of freedom from loss of PP were generated for each of the
10,000 simulation sets. The six different methods averaged from 67.9% to 81.8%.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Survival analyses of freedom from loss of PP vary substantially
according to the methods employed. These may lead to misrepresentation of results
from clinical trials. The development of a uniﬁed approach is advocated.
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Background: Intermittent claudication affects 2.5% of women and 5% of men over
the age of 60. Advanced age, diabetes, and renal insufﬁciency predispose patients to
intra-arterial calcium which is a predictor of poor endovascular treatment success.
Methods of treating peripheral arterial disease (PAD) have evolved and now include
minimally-invasive endovascular procedures, utilizing orbital atherectomy (OA)
which can modify calciﬁc plaque both above and below-the-knee.
Methods: Three consecutive CONFIRM patient registries were conducted prospec-
tively and enrolled patients on an "all comers" basis to evaluate the use of orbital
atherectomy in peripheral lesions of the lower extremities. Analysis of all 3135
patients enrolled in the CONFIRM I-III registries revealed 1698 patients with clau-
dication (Rutherford Class 1-3) and documented lesion morphology. We analyzed the
CONFIRM series to compare procedural complications after OA treatment of lesions
with moderate/severe calcium versus lesions without moderate/severe calcium in
claudicant patients.
Results: Eighty-two percent of claudicants treated with OA had moderate/severely
calciﬁed lesions. There was no signiﬁcant difference in the percentage of perforations
(0.6% vs 0%), slow ﬂow (2.9% vs 2.6%), closure (1.4% vs 2.3%), spasm (3.8% vs
6.3%), embolism (1.7% vs 2.6%), or thrombus (1.1% vs 1.3%), in claudicants with
moderate/severely calciﬁed lesions vs without moderate/severely calciﬁed lesions,
respectively. Claudicants with moderate/severe calcium had fewer dissections than
those without moderate/severely calciﬁed lesions (10.9% vs 16.2%, p¼0.004).
Conclusions: The majority of the claudicant patients in this study had lesions with
moderate to severe calciﬁcation, yet the occurrence of adverse events was low after
treatment with orbital atherectomy. Orbital atherectomy is a safe tool for restoring
blood ﬂow in the lower extremities of claudicant patients regardless of arterial calcium
burden.
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Background: Prosthetic aortic grafts remain problematic despite enhancements in
biomaterials and production prosthetics, improved surgical techniques, and a better
understanding of the pathogenesis of graft infections. Previously, we investigated
a locally developed technique of bonding aortic grafts with 3 antimicrobials to prevent
early (within 2 weeks) direct perioperative bacterial contamination related to aortic
graft operations. In the current phase, we attempted to determine whether the
concentrations of the antimicrobials bonded to the graft are sufﬁcient to prevent
postoperative aortic graft infections for a longer period (8 weeks).
Methods: Nine Sinclair miniature pigs received a 6-mm vascular Dacron graft in the
infrarenal portion of the abdominal aorta. Six pigs received grafts chemically bonded
with 60-mg/mL solutions of rifampin, minocycline, and chlorhexidine; 3 pigs received
unbonded grafts. Before implantation, the 6 bonded grafts and 2 of the unbonded
grafts were immersed for 15 minutes in a 2-mL bacterial solution containing 1 to
2107 colony-forming units (CFUs)/mL of Staphylococcus aureus (ATCC 29213);
the 3rd unbonded graft served as a control. The pigs were observed for 8 weeks after
graft implantation; then the pigs were sacriﬁced, and the grafts were excised. Beforeacts/POSTER/Endovascular Intervention B165
